FDA approves selpercatinib for lung and thyroid cancers with RET gene mutations or fusions
Hematology/Oncology News Burst
Source: FDA Center for Drug Evaluation and Research - What's New - Category: Drugs & Pharmacology Authors: FDA Source Type: news
More News: Cancer | Cancer & Oncology | Drugs & Pharmacology | Genetics | Hematology | Thyroid | Thyroid Cancer